{
    "organizations": [],
    "uuid": "05362130ca2fda26dbea2938d1366872ca3c4edd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-launches-rebinyn-in-t/brief-novo-nordisk-launches-rebinyn-in-the-united-states-for-people-with-hemophilia-b-idUSFWN1PY1H3",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk Launches Rebinyn In The United States For People With Hemophilia B",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 8 (Reuters) - Novo Nordisk A/S:\n* NOVO NORDISK LAUNCHES REBINYNÂ® IN THE UNITED STATES FOR PEOPLE WITH HEMOPHILIA B Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-08T22:32:00.000+02:00",
    "crawled": "2018-02-09T16:55:22.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "novo",
        "nordisk",
        "novo",
        "nordisk",
        "launch",
        "united",
        "state",
        "people",
        "hemophilia",
        "b",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}